Nuclear Power is receiving a strong boost! The State Council has approved the Zhejiang Sanmen Phase III project and other Nuclear Power projects.

Analysis suggests that this is undoubtedly a significant Bullish factor for the Nuclear Power Industry Chain.

Brokerage ChinaApr 28 07:16

Adding insult to injury! The core subsidiary of Shandong Sinobioway Biomedicine has been halted from production, with a revenue share of 60% | Quick read announcement.

① A subsidiary of Shandong Sinobioway Biomedicine responsible for the production and sale of interferon products has been subjected to risk control measures that involve the suspension of production and sales due to failing the Pharmaceutical GMP compliance inspection. ② Previously, Shandong Sinobioway Biomedicine's interferon α2b spray was recalled from shelves due to inspection results indicating that its "biological activity does not meet regulations."

cls.cnApr 24 23:07

Humanoid robot competition: a "technical coming-of-age ceremony" where "flops" and "evolution" occur simultaneously.

① The champion team from Tian Gong, CTO Tang Jian of the Peking Humanoid Robot Innovation Center, told the Star Daily reporter, "The half marathon competition is mainly a limit test for the robot's Hardware and Software motion algorithm, or the stability and reliability of the robot's 'little brain'." ② The Wuxi embodied intelligence sports event opening tomorrow, along with the upcoming robot combat competition held by Yushu, will undoubtedly attract more attention for 'inspection.'

cls.cnApr 24 21:16

Is the major source of revenue for PKU HealthCare Corp. lost or acquired by a 'mystery buyer,' revealing symptoms of an 'aftershock'? | Quick read of the announcement.

① Related revenue accounts for nearly one third of PKU HealthCare Corp.'s revenue, and the Net income is almost completely covered; ② Last December, after being acquired by mysterious investor Xu Xiren from Zhejiang, PKU HealthCare Corp. needs to separate from the "Peking University" brand; ③ Since the acquisition occurred, PKU HealthCare Corp.'s Market Cap has shrunk by nearly one fifth.

cls.cnApr 22 18:43

Siasun Robot&Automation team "operating" ignites the buzz! The Industry Chain frequently updates progress. Analysts suggest that the next 2-3 years may be a critical period for mass production.

① This year, the Guangzhou Fair has set up a special area for service robots for the first time, and exhibitors revealed that customers made deposits on the spot, with some even stating that "9 out of 10 display models were booked." ② Currently, there are 11 major humanoid Ontology manufacturers in China that have started mass production plans for 2024, with several manufacturers planning to produce over a thousand units in 2025. ③ Analysts state that the next 2-3 years will be a crucial period for large-scale mass production and delivery of robots.

cls.cnApr 22 09:29

Iflytek Co.,ltd.: Q1 revenue increased by 27.7%, accelerating the commercialization of the Spark large model.

Iflytek Co.,ltd.'s Q1 revenue grew by 27.7%, with the commercialization of the Spark large model accelerating. Key points include financial performance: revenue of 4.658 billion yuan, a year-on-year increase of 27.74%; net loss of 0.193 billion yuan, a year-on-year narrowing of 35.68%; non-GAAP net loss of 0.228 billion yuan, a year-on-year narrowing of 48.29%. Cash flow improved: the net cash flow from operating activities was -0.712 billion yuan, a year-on-year improvement of 48.54%. R&D investment: continued to increase investment in the "Iflytek Spark" large model strategy, with R&D expenses reaching 0.947 billion yuan, a year-on-year increase of 12.4%. Business highlights: on April 20, the Spark Deep Reasoning Model was released.

wallstreetcnApr 21 20:39